{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T17:22:31Z","timestamp":1778433751820,"version":"3.51.4"},"reference-count":20,"publisher":"Japanese Circulation Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2020,2,25]]},"DOI":"10.1253\/circj.cj-19-0981","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T17:05:40Z","timestamp":1580922340000},"page":"509-515","source":"Crossref","is-referenced-by-count":19,"title":["Fasting and Non-Fasting Triglycerides and Risk of Cardiovascular Events in Diabetic Patients Under Statin Therapy"],"prefix":"10.1253","volume":"84","author":[{"given":"Hayato","family":"Tada","sequence":"first","affiliation":[{"name":"Department of Cardiology, Kanazawa University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kanazawa University Graduate School of Medicine"},{"name":"Innovative Clinical Research Center, Kanazawa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Innovative Clinical Research Center, Kanazawa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Itoh","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Komuro","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Yamagishi","sequence":"additional","affiliation":[{"name":"Osaka University of Human Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Takamura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kanazawa University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masa-aki","family":"Kawashiri","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kanazawa University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kannel WB. Lipids, diabetes, and coronary heart disease: Insights from the Framingham Study. <i>Am Heart J<\/i> 1985; 110: 1100\u20131107.","DOI":"10.1016\/0002-8703(85)90224-8"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Xie J, Ikram MK, Cotch MF, Klein B, Varma R, Shaw JE, et al. Association of diabetic macular edema and proliferative diabetic retinopathy with cardiovascular disease: A systematic review and meta-analysis. <i>JAMA Ophthalmol<\/i> 2017; 135: 586\u2013593.","DOI":"10.1001\/jamaophthalmol.2017.0988"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, et al. Intensive treat-to-target statin therapy in high-risk Japanese patients with hypercholesterolemia and diabetic retinopathy: Report of a randomized study. <i>Diabetes Care<\/i> 2018; 41: 1275\u20131284.","DOI":"10.2337\/dc17-2224"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tada H, Kawashiri MA, Nomura A, Yoshimura K, Itoh H, Komuro I, et al. Serum triglycerides predict first cardiovascular events in diabetic patients with hypercholesterolemia and retinopathy. <i>Eur J Prev Cardiol<\/i> 2018; 25: 1852\u20131860.","DOI":"10.1177\/2047487318796989"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Madsen CM, Varbo A, Nordestgaard BG. Unmet need for primary prevention in individuals with hypertriglyceridaemia not eligible for statin therapy according to European Society of Cardiology\/European Atherosclerosis Society guidelines: A contemporary population-based study. <i>Eur Heart J<\/i> 2018; 39: 610\u2013619.","DOI":"10.1093\/eurheartj\/ehx659"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tada H, Kawashiri MA. Genetic variations, triglycerides, and atherosclerotic disease. <i>J Atheroscler Thromb<\/i> 2019; 26: 128\u2013131.","DOI":"10.5551\/jat.ED102"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, et al. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan: 2012 version. <i>J Atheroscler Thromb<\/i> 2014; 21: 296\u2013298.","DOI":"10.5551\/jat.19737"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Tada H, Nohara A, Inazu A, Mabuchi H, Kawashiri MA. Remnant lipoproteins and atherosclerotic cardiovascular disease. <i>Clin Chim Acta<\/i> 2019; 490: 1\u20135.","DOI":"10.1016\/j.cca.2018.12.014"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC\/EAS guidelines for the management of dyslipidaemias. <i>Eur Heart J<\/i> 2016; 37: 2999\u20133058.","DOI":"10.1093\/eurheartj\/ehw272"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. <i>JAMA<\/i> 2007; 298: 309\u2013316.","DOI":"10.1001\/jama.298.3.309"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG. Nonfasting triglycerides and risk of ischemic stroke in the general population. <i>JAMA<\/i> 2008; 300: 2142\u20132152.","DOI":"10.1001\/jama.2008.621"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. J\u00f8rgensen AB, Frikke-Schmidt R, West AS, Grande P, Nordestgaard BG, Tybj\u00e6rg-Hansen A. Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction. <i>Eur Heart J<\/i> 2013; 34: 1826\u20131833.","DOI":"10.1093\/eurheartj\/ehs431"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ueshima K, Itoh H, Kanazawa N, Komuro I, Nagai R, Takeuchi M, et al. Rationale and design of the standard versus intensive statin therapy for hypercholesterolemic patients with diabetic retinopathy (EMPATHY) study: A randomized controlled trial. <i>J Atheroscler Thromb<\/i> 2016; 23: 976\u2013990.","DOI":"10.5551\/jat.33563"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. <i>Biometrics<\/i> 1988; 44: 837\u2013845.","DOI":"10.2307\/2531595"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sever PS, Dahl\u00f6f B, Poulter NR, Wedel H, Beevers G, Caulfield M, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial\u2013Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial. <i>Lancet<\/i> 2003; 361: 1149\u20131158.","DOI":"10.1016\/S0140-6736(03)12948-0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. SEARCH Study Collaborative Group, Bowman L, Armitage J, Bulbulia R, Parish S, Collins R. Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): Characteristics of a randomized trial among 12064 myocardial infarction survivors. <i>Am Heart J<\/i> 2007; 154: 815\u2013823.","DOI":"10.1016\/j.ahj.2007.06.034"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. TG and HDL Working Group of the Exome Sequencing Project, National Heart, Lung, and Blood Institute, Crosby J, Peloso GM, Auer PL, Crosslin DR, Stitziel NO, Lange LA, et al. Loss-of-function mutations in APOC3, triglycerides, and coronary disease. <i>N Engl J Med<\/i> 2014; 371: 22\u201331.","DOI":"10.1056\/NEJMoa1307095"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Nordestgaard BG, Langsted A, Mora S, Kolovou G, Baum H, Bruckert E, et al. Fasting is not routinely required for determination of a lipid profile: Clinical and laboratory implications including flagging at desirable concentration cut-points. A joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. <i>Eur Heart J<\/i> 2016; 37: 1944\u20131958.","DOI":"10.1093\/eurheartj\/ehw152"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Iso H, Imano H, Yamagishi K, Ohira T, Cui R, Noda H, et al. Fasting and non-fasting triglycerides and risk of ischemic cardiovascular disease in Japanese men and women: The Circulatory Risk in Communities Study (CIRCS). <i>Atherosclerosis<\/i> 2014; 237: 361\u2013368.","DOI":"10.1016\/j.atherosclerosis.2014.08.028"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Cho KI, Yu J, Hayashi T, Han SH, Koh KK. Strategies to overcome residual risk during statins era. <i>Circ J<\/i> 2019; 83: 1973\u20131979.","DOI":"10.1253\/circj.CJ-19-0624"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/84\/3\/84_CJ-19-0981\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T22:21:24Z","timestamp":1582928484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/84\/3\/84_CJ-19-0981\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,25]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-19-0981","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,25]]}}}